View in EDS HTML Full Text PDF Full Text

Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group.

Saved in:
Bibliographic Details
Title: Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group.
Authors: Lin, Ray S.1 (AUTHOR), Mukhopadhyay, Pralay2 (AUTHOR), Roychoudhury, Satrajit3 (AUTHOR), Anderson, Keaven M.4 (AUTHOR), Hu, Tianle5 (AUTHOR), Huang, Bo6 (AUTHOR), Leon, Larry F.4 (AUTHOR), Liao, Jason J. Z.7 (AUTHOR), Lin, Ji8 (AUTHOR), Liu, Rong9 (AUTHOR), Luo, Xiaodong10 (AUTHOR), Mai, Yabing11 (AUTHOR), Qin, Rui12 (AUTHOR), Tatsuoka, Kay13 (AUTHOR), Wang, Yang14 (AUTHOR), Ye, Jiabu4 (AUTHOR), Zhu, Jian15 (AUTHOR), Chen, Tai-Tsang16 (AUTHOR), Iacona, Renee17 (AUTHOR)
Source: Statistics in Biopharmaceutical Research. Apr-Jun2023, Vol. 15 Issue 2, p312-314. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19466315
DOI:10.1080/19466315.2022.2103180